Immunizations for pharmacy

McKesson has been awarded a Texas contract (Reference: HHSTX-7-0000409209) effective July 15, 2026, for the provision of immunizations and pharmaceutical products to support pharmacy operations. The contract encompasses a range of allergenic extracts and specialized pharmaceutical compounds, including alfalfa allergenic extract, horse epithelium allergenic extract, and alder allergenic extract, along with therapeutic agents such as vestronidase alfa and naloxegol. These products fall under the National Institute of Governmental Purchasing (NIGP) classification for miscellaneous drugs and pharmaceuticals.

The specific contract value, cumulative value, and detailed period of performance metrics are not disclosed in the available award documentation. Similarly, the specific awarding organization, county of performance, and complete delivery locations within Texas have not been detailed in the materials provided. McKesson, as the prime contractor, is responsible for fulfilling all obligations associated with the supply and delivery of the enumerated pharmaceutical products in accordance with Texas state procurement requirements.